Sermoreline pour les femmes de plus de 40 ans : anti-âge, perte de gras et meilleur sommeil
Novo Pharma Research Team
Recherche Novo Pharma · synthèse de littérature révisée par les pairs
Sermoreline pour les femmes de plus de 40 ans : anti-âge, perte de gras et meilleur sommeil
Meta Description : La sermoreline est l'analogue GHRH le plus étudié cliniquement pour les femmes de plus de 40 ans. Découvrez comment elle améliore le sommeil, réduit la graisse viscérale, soutient la densité osseuse et restaure des niveaux jeunes de GH — avec le dosage (100-300 mcg au coucher) et le calendrier.
Keywords : sermoreline pour femmes, sermoreline anti-âge, sermoreline après 40 ans, sermoreline dosage femmes
Références :
- Iranmanesh A, et al. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73(5):1081-1088. PMID: 1939523
- Leung KC, et al. Estrogen regulation of growth hormone action. Endocr Rev. 2004;25(5):693-721. PMID: 15466938
- Van Cauter E, et al. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000;284(7):861-868. PMID: 10938176
- Frohman LA, et al. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest. 1986;78(4):906-913. PMID: 3093527
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. PMID: 18031173
- Corpas E, et al. Human growth hormone and human aging. Endocr Rev. 1993;14(1):20-39. PMID: 8491153
- Kravitz HM, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979-990. PMID: 18652093
- Rudman D, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6. PMID: 2355952
- Rudman D, et al. Effects of human growth hormone on body composition in elderly men. Horm Res. 1991;36(Suppl 1):73-81. PMID: 1806490
- Ohlsson C, et al. Growth hormone and bone. Endocr Rev. 1998;19(1):55-79. PMID: 9494780
- Hoffman AR, et al. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(5):2048-2056. PMID: 15126520
- Jorgensen JO, et al. Growth hormone and thyroid function. Horm Res. 1994;42(4-5):164-167. PMID: 7868069
Cet article est publié à des fins éducatives uniquement et ne constitue pas un avis médical. Consultez un professionnel de la santé avant d'utiliser tout composé de recherche.
All compounds discussed and sold through Novo Pharma are intended strictly for laboratory and in-vitro research purposes. Products are not for human or animal consumption, not for use in food, cosmetics, or medicinal applications, and not for any therapeutic or diagnostic use.
The information on this page is provided for educational context and documents findings from published research. It is not medical advice, not a recommendation, and not a suggestion that any compound be used outside of a controlled research environment. Consult a qualified healthcare professional for any medical or health-related decision.
By purchasing, you confirm you are a qualified researcher, accept full responsibility for proper handling and disposal, and agree to use compounds in compliance with all applicable local, provincial, and federal laws.